Inactief instrument

Andere talen Nichi-Iko Pharmaceutical Co., Ltd.

Aandelen

4541

JP3687200000

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Nakakita Yakuhin Co., ltd. acquired Yakuhan Pharmaceutical Co., Ltd. from Nichi-Iko Pharmaceutical Co., Ltd.	01-08-23
Nichi-Iko Pharmaceutical Co., Ltd.(TSE:4541) dropped from S&P Global BMI Index	20-03-23
Japan Shares End Flat on Last Trading Day of 2022; Nichi-Iko Pharmaceutical Shares Plummet 24%	30-12-22
Nichi-Iko Pharmaceutical Secures 98.5 Billion Yen of Debt Relief, Plans 20 Billion Yen Share Allotment; Shares Plunge 20%	30-12-22
Nichi-Iko Pharmaceutical More Than Triples Fiscal H1 Profit	12-12-22
Nichi-Iko Pharmaceutical Co., Ltd. announced that it expects to receive Ã‘19.998404811 billion in funding from Godo Kaisha JSD	14-11-22
Japan Index Trades Steadily in Red; Round One Shares Gain 9% as May Sales Exceed Pre-Pandemic Level	10-06-22
Chugai Appeals Tokyo Court's Dismissal of Patent Infringement Lawsuit Against Sawai, Nichi-iko Pharmaceutical	10-06-22
Court Denies Chugai's Claim in Lawsuit Against Sawai, Nichi-iko	30-05-22
Nichi-Iko Pharmaceutical's Nine-Month Profit Soars	10-03-22
Nichi Iko Pharmaceutical : 〔Delayed〕Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2022（IFRS）	09-03-22
Nichi-Iko Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022	09-03-22
Court Denies Chugai's Claim in Lawsuit Against Sawai, Nichi-iko and Nissan Chemical	25-02-22
Nichi Iko Pharmaceutical : 〔Delayed〕Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2022 (IFRS)	03-12-21
Nichi-Iko Pharmaceutical Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2022	03-12-21
Nichi Iko Pharmaceutical : 〔Delayed〕Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2022 (IFRS)	06-09-21
Nichi-Iko Pharmaceutical Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2021	06-09-21
Nichi-Iko Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Second Quarter and Full Year of Fiscal Ending March 31, 2022	06-09-21
Nichi-Iko Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2022	06-09-21
Nichi-Iko Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2022	06-09-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Nichi-Iko Pharmaceutical Co., Ltd.

Aandelen

4541

JP3687200000

Andere talen

Filters